SND 919 tablets

· Boehringer Ingelheim

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for SND 919 tablets, covering 2012-05-21 to 2012-05-21. Get the full timeline:

Most recent: Clinical Trial Update: Long-term Administration Study of SND 919 Tablets in Parkinson's Disease [Phase 3]